Deven Parmar
ScholarGPS® ID: 56326875472441
Affiliation History
Field
Medicine
Discipline
Gastroenterology
Top Specialties
Pharmacokinetics | Cancer
Metrics Summary
Publication Count
20
Predicted Citations
747
Predicted h-index
11
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Naunyn-Schmiedeberg's Archives of Pharmacology, volume 397, issue 7, pages 4737-4745 (2024). |
Pharmacokinetics and Safety Evaluation of Single‐Dose Saroglitazar Magnesium in Subjects with Hepatic Impairment (journal article) Clinical Pharmacology in Drug Development, volume 12, issue 12, pages 1142-1155 (2023). |
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis (journal article) Clinical Gastroenterology and Hepatology, volume 21, issue 10, pages 2597-2605.e2 (2023). |
Clinical Pharmacology in Drug Development, volume 12, issue 2, pages 202-211 (2023). |
Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients (journal article) Liver Transplantation, volume 29, issue 9, pages 979-986 (2023). |
Clinical Breast Cancer, volume 22, issue 4, pages 300-307 (2022). |
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND) (journal article) American Journal of Nephrology, volume 53, issue 5, pages 352-360 (2022). |
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis (journal article) Clinical Gastroenterology and Hepatology, volume 19, issue 12, pages 2670-2672 (2021). |
Estimation of ZYKR1 in human urine and plasma utilizing LC-MS/MS positive electrospray ionization; a kappa opioid receptor (KOR) agonist (journal article) Journal of Chromatography B, volume 1185 (2021). |
eClinicalMedicine, volume 38 (2021). |
A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis (journal article) Clinical and Translational Gastroenterology, volume 12, issue 4, pages e00327- (2021). |
Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial (journal article) Hepatology, volume 74, issue 4, pages 1809-1824 (2021). |
Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study (journal article) Acta Diabetologica, volume 57, issue 7, pages 809-818 (2020). |
New drugs and clinical trials rules 2019: Changes in responsibilities of the ethics committee (journal article) Perspectives in Clinical Research, volume 11, issue 1, pages 37- (2020). |
Cardiovascular Diabetology, volume 18, issue 1 (2019). |
SSRN Electronic Journal (2019). |
Outcomes of Desidustat Treatment in People with Anemia and Chronic Kidney Disease: A Phase 2 Study (journal article) American Journal of Nephrology, volume 49, issue 6, pages 470-478 (2019). |
Phase IV Clinical Trials of Biosimilars for Cancer: Extrapolation of the ‘Basket Concept’ of Trials (journal article) Journal of Pharmacy Practice and Community Medicine, volume 4, issue 3, pages 131-131 (2018). |
Clinical Therapeutics, volume 40, issue 3, pages 456-468.e1 (2018). |
Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects (journal article) Clinical Drug Investigation (2018). |